Latest Breaking News On - Nikolaos kartalis - Page 1 : comparemela.com

MRI Contrast Agent Orviglance Hepatic Impairment Data Presented by Ascelia Pharma at ESGAR 2023

Ascelia Pharma recently presented data from its Orviglance Hepatic Impairment study showing that Orviglance, a non-gadolinium oral contrast agent, has the potential to be used in patients with any degree of liver impairment. The data was presented during the June 14-16 European Society of Gastrointestinal and Abdominal Radiology (ESGAR), held in Valencia, Spain.

United statesAlessandro furlanNikolaos kartalisAscelia pharmaAscelia pharmapresentedNadilka hettiarachchigeKarolinska university hospitalGlobal medical affairs at ascelia pharmaDepartment of radiology huddingePittsburgh liver research centerDrug administrationEuropean society of gastrointestinalTexas liver instituteOrviglance hepatic impairmentEuropean societyAbdominal radiology

Ascelia Pharma presented Orviglance Hepatic Impairment Data and hosted a Q&A with liver imaging experts at the 2023 ESGAR Annual Meeting

BioPharma

United statesAscelia pharmaNikolaos kartalisAlessandro furlanNadilka hettiarachchigeTexas liver instituteEuropean society of gastrointestinalDepartment of radiology huddingeGlobal medical affairs at ascelia pharmaDrug administrationKarolinska university hospitalHepatic impairment studyEuropean societyAbdominal radiologyAnnual meetingOrphan drug designation

Meet Persephone, the robot tour guide at Greece s Alistrati Cave who can speak 33 languages

Meet Persephone, the robot tour guide at Greece s Alistrati Cave who can speak 33 languages
euronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euronews.com Daily Mail and Mail on Sunday newspapers.

Perifereia kentrikis makedoniasNikolaos kartalisEvdokia karaferaNational technologyResearch foundationAlistrati caveScientific director